Device
Restylane Lidocaine
Restylane Lidocaine is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_4
1
25%
Ph phase_3
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
completed375%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Pain and Safety of Restylane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds
NCT02918721
completedphase_4
Performance and Safety of Restylane Lidocaine for Treatment of Depressed Facial Acne Scars
NCT03127384
completedphase_3
Restylane + Lidocaine and Restylane Lyft for the Treatment of Nasolabial Folds
NCT04174131
unknownnot_applicable
To Evaluate the Efficacy and Safety of Injection With HARA as Compared to Restylane® Lidocaine in Temporary Correction of Nasolabial Folds
NCT04224649
Clinical Trials (4)
Showing 4 of 4 trials
NCT02918721Not Applicable
Pain and Safety of Restylane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds
NCT03127384Phase 4
Performance and Safety of Restylane Lidocaine for Treatment of Depressed Facial Acne Scars
NCT04174131Phase 3
Restylane + Lidocaine and Restylane Lyft for the Treatment of Nasolabial Folds
NCT04224649Not Applicable
To Evaluate the Efficacy and Safety of Injection With HARA as Compared to Restylane® Lidocaine in Temporary Correction of Nasolabial Folds
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4